Items where Author is "Wellsted, David M"

Item Type No Grouping

Rationale and design of "Can Very Low Dose Rivaroxaban (VLDR) in addition to dual antiplatelet therapy improve thrombotic status in acute coronary syndrome (VaLiDate-R)" study : A randomised trial modulating endogenous fibrinolysis in patients with acute coronary syndrome. (2019) Ying X Gue, Rahim Kanji, David M Wellsted, Manivannan Srinivasan, Solange Wyatt and Diana A Gorog